Beslagsmed Kasper Brøndel ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  3.1% 2.5% 2.0% 2.2% 1.8%  
Credit score (0-100)  58 62 68 65 70  
Credit rating  BBB BBB A BBB A  
Credit limit (kDKK)  0.0 0.0 0.3 0.1 0.8  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  1,398 1,456 1,579 1,702 1,524  
EBITDA  601 640 694 776 597  
EBIT  584 596 645 726 527  
Pre-tax profit (PTP)  579.7 591.8 640.0 715.9 527.1  
Net earnings  449.7 457.8 493.0 552.1 398.9  
Pre-tax profit without non-rec. items  580 592 640 716 527  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  158 286 290 240 171  
Shareholders equity total  584 642 735 887 886  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  828 1,122 1,107 1,177 1,310  

Net Debt  -598 -580 -573 -781 -1,000  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  -100.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,398 1,456 1,579 1,702 1,524  
Gross profit growth  0.4% 4.1% 8.5% 7.8% -10.4%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  828 1,122 1,107 1,177 1,310  
Balance sheet change%  -8.4% 35.5% -1.4% 6.4% 11.2%  
Added value  601.5 639.9 694.0 775.5 597.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  89 84 -45 -99 -140  

Net sales trend  -1.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  41.8% 40.9% 40.8% 42.7% 34.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  67.5% 61.1% 58.0% 63.6% 42.4%  
ROI %  103.1% 97.2% 93.9% 89.5% 59.5%  
ROE %  79.4% 74.7% 71.6% 68.1% 45.0%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  70.6% 57.2% 66.4% 75.3% 67.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -99.4% -90.7% -82.6% -100.7% -167.5%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  2.8 1.7 2.2 3.2 2.7  
Current Ratio  2.8 1.7 2.2 3.2 2.7  
Cash and cash equivalent  598.1 580.4 573.0 781.1 1,000.1  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  426.6 356.3 445.1 646.6 715.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0